Druggable genome in attention deficit/hyperactivity disorder and its co-morbid conditions. New avenues for treatment

Attention-Deficit/Hyperactivity Disorder (ADHD) is a common neurodevelopmental disorder with only symptomatic care available. Genome-wide association (GWA) studies can provide a starting point in the search for novel drug targets and possibilities of drug repurposing. Here, we explored the druggable...

Descripción completa

Detalles Bibliográficos
Autores principales: Hegvik, Tor-Arne, Waløen, Kai, Pandey, Sunil K., Faraone, Stephen V., Haavik, Jan, Zayats, Tetyana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7165040/
https://www.ncbi.nlm.nih.gov/pubmed/31628418
http://dx.doi.org/10.1038/s41380-019-0540-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7165040/
https://www.ncbi.nlm.nih.gov/pubmed/31628418
http://dx.doi.org/10.1038/s41380-019-0540-z

Ejemplares similares